PHARMACIE ANS SENTERRE
ActiveSummary
PHARMACIE ANS SENTERRE has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €42,430 and a net result of €22,090. Equity has been growing by about 20% per year since 2018. Its solvency ranks better than 45% of 5,039 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
Overview
Official details
Source: KBO- Status
- Active since 17-01-2001 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Establishment unit
- 2.094.264.444 4430 Ans, since 01-02-2001
- Financial year end
- 31 December
- Peppol
- Reachable since 04-11-2025
Board and ownership
- ATTE GESTIONManaging director · permanent representative ATTE Eddy
- NAHIMANA EmmanuelDirector · since 14-02-2024
- ATTE GESTION99.96%· score 662025 annual accounts of ATTE GESTION
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.5%
- Gross margin
- €25,091
- ▲ 151%
- Turnover
- ≈ €110,000
- estimated
- Profit
- €22,090
- ▲ 301%
- Equity
- €42,430
- ▲ 109%
- Total assets
- €132,785
- ▲ 14.4%
- 2025 accounts filed 31 days after the deadline
Score breakdownraises riskLast filed accounts filed 31 days late; 2 of the last 3 accounts lateSize: total assets €132,785Sector: Retail trade (NACE 47)lowers riskFounded in 2001Show the evidence
Checked score
About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 47% of them on solvency, 23% on liquidity, 84% on profitability and 93% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 16 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
- Caution: Less equity than 83% of companies in retail tradesector median €447,349 · 5,040 companies €42,430 View
Recent changes
- · Gazette deed Reappointments: ATTE GESTION (director) and NAHIMANA Emmanuel (director)Permanent representative: ATTE Eddy · Appointment: ATTE GESTION (managing director)
Comparable companies
These companies have the same main activity as PHARMACIE ANS SENTERRE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €126,000 and €186,000, founded between 1993 and 2007.
| Company | Total assets | Gross margin |
|---|---|---|
| PHARMACIE ANS SENTERRE Ans | €132,785 | €25,091 |
| APOTHEEK DE SCHEERDER Gent | €128,527 | €23,955 |
| MONT ROYAL Brussel | €126,135 | €18,242 |
| APOTHEEK VAN DER PLAS Dilbeek | €176,800 | €23,245 |
| MEDISAME Stabroek | €184,789 | €19,805 |
| PHARMACIE ROLAND RUTH Liège | €185,867 | €27,542 |
| X - PHARMA Verviers | €150,150 | €15,417 |
Key facts about PHARMACIE ANS SENTERRE
- What is the company number of PHARMACIE ANS SENTERRE?
- The company number of PHARMACIE ANS SENTERRE is 0473.720.185. The VAT number is the same number with BE in front: BE 0473.720.185.
- Where is PHARMACIE ANS SENTERRE based?
- The registered office is at Rue Walthère Jamar 151, 4430 Ans.Company details
- What does PHARMACIE ANS SENTERRE do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of PHARMACIE ANS SENTERRE?
- The legal form of PHARMACIE ANS SENTERRE is Public limited company (NV).
- When was PHARMACIE ANS SENTERRE founded?
- PHARMACIE ANS SENTERRE was founded on 17-01-2001.
- Is PHARMACIE ANS SENTERRE still active?
- Yes, PHARMACIE ANS SENTERRE is an active enterprise in the KBO register.
- How many employees does PHARMACIE ANS SENTERRE have?
- PHARMACIE ANS SENTERRE had an average of 0.2 full-time equivalents in financial year 2019, according to the filed annual accounts.Financials
- What is the turnover of PHARMACIE ANS SENTERRE?
- The turnover in financial year 2025 is ≈ €110,000. This figure is estimated from the gross margin of €25,091 and 74 comparable companies (NACE 477). It probably lies between €63,000 and €210,000.
- Is PHARMACIE ANS SENTERRE profitable?
- In financial year 2025, PHARMACIE ANS SENTERRE made a profit of €22,090.
- Where can I find the annual accounts of PHARMACIE ANS SENTERRE?
- PHARMACIE ANS SENTERRE filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PHARMACIE ANS SENTERRE due?
- PHARMACIE ANS SENTERRE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.